Frank D. Lee serves as Executive at Forma Therapeutics Holdings, Inc., where they oversee executive responsibilities. Since joining the company, Frank D. Lee has executed 11 insider transactions totaling $397.7K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 30, 2026 involved selling 41,488 shares valued at $852.2K.
Frank D. Lee currently holds 399,012.84 shares of Forma Therapeutics Holdings, Inc. (FMTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Frank D. Lee has been a net seller of FMTX stock. They have purchased $100.0K and sold $297.7K worth of shares.
Frank D. Lee's most recent insider trade was on Jan 30, 2026, when they sold 41,488 shares at $20.54 per share.
Get notified when new Form 4 filings are submitted
| $24.46 |
| Discretionary |
| Aug 21, 2025 | BHC | $121.9K | Sale | 15,912 | $7.66 | Discretionary |
| Aug 12, 2024 | PCRX | $100.0K | Purchase | 8,264 | $12.10 | Discretionary |
| May 17, 2024 | BHC | $0 | Award | 35,360 | $N/A | Discretionary |
| Jan 2, 2024 | PCRX | $0 | Award | 99,520 | $N/A | Discretionary |
| Oct 14, 2022 | FMTX | $0 | Tender | 201,436 | $N/A | Discretionary |
| Feb 28, 2022 | FMTX | $0 | Award | 121,667 | $N/A | Discretionary |
| Feb 23, 2022 | FMTX | $175.9K | Sale | 17,981 | $9.78 | Discretionary |
| Feb 26, 2021 | FMTX | $0 | Award | 57,750 | $N/A | Discretionary |
| Feb 26, 2021 | FMTX | $0 | Award | 40,000 | $N/A | Discretionary |